ArticleCancers2020

Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support.

Yasser Perera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.